267 related articles for article (PubMed ID: 20019066)
21. Perforin and lymphohistiocytic proliferative disorders.
Katano H; Cohen JI
Br J Haematol; 2005 Mar; 128(6):739-50. PubMed ID: 15755277
[TBL] [Abstract][Full Text] [Related]
22. Mutations in the perforin gene in children with hemophagocytic lymphohistiocytosis.
Lu G; Xie ZD; Shen KL; Ye LJ; Wu RH; Liu CY; Jin YK; Yang S
Chin Med J (Engl); 2009 Dec; 122(23):2851-5. PubMed ID: 20092789
[TBL] [Abstract][Full Text] [Related]
23. Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosis.
Horne A; Ramme KG; Rudd E; Zheng C; Wali Y; al-Lamki Z; Gürgey A; Yalman N; Nordenskjöld M; Henter JI
Br J Haematol; 2008 Oct; 143(1):75-83. PubMed ID: 18710388
[TBL] [Abstract][Full Text] [Related]
24. Functional impact of A91V mutation of the PRF1 perforin gene.
Martínez-Pomar N; Lanio N; Romo N; Lopez-Botet M; Matamoros N
Hum Immunol; 2013 Jan; 74(1):14-7. PubMed ID: 23073290
[TBL] [Abstract][Full Text] [Related]
25. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome.
Fall N; Barnes M; Thornton S; Luyrink L; Olson J; Ilowite NT; Gottlieb BS; Griffin T; Sherry DD; Thompson S; Glass DN; Colbert RA; Grom AA
Arthritis Rheum; 2007 Nov; 56(11):3793-804. PubMed ID: 17968951
[TBL] [Abstract][Full Text] [Related]
27. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.
Behrens EM; Beukelman T; Paessler M; Cron RQ
J Rheumatol; 2007 May; 34(5):1133-8. PubMed ID: 17343315
[TBL] [Abstract][Full Text] [Related]
28. Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
Vandenhaute J; Wouters CH; Matthys P
Front Immunol; 2019; 10():3089. PubMed ID: 32010140
[TBL] [Abstract][Full Text] [Related]
29. [Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: analysis of 13 patients].
Shi H; Wang HW; Cheng PX; Hu XF; Liu QJ; Wan LJ
Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):812-7. PubMed ID: 17274866
[TBL] [Abstract][Full Text] [Related]
30. Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis.
Zeng HS; Xiong XY; Wei YD; Wang HW; Luo XP
World J Pediatr; 2008 May; 4(2):97-101. PubMed ID: 18661762
[TBL] [Abstract][Full Text] [Related]
31. Correlation between phenotypic heterogeneity and gene mutational characteristics in familial hemophagocytic lymphohistiocytosis (FHL).
Ueda I; Ishii E; Morimoto A; Ohga S; Sako M; Imashuku S
Pediatr Blood Cancer; 2006 Apr; 46(4):482-8. PubMed ID: 16365863
[TBL] [Abstract][Full Text] [Related]
32. Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids.
Bruck N; Suttorp M; Kabus M; Heubner G; Gahr M; Pessler F
J Clin Rheumatol; 2011 Jan; 17(1):23-7. PubMed ID: 21169853
[TBL] [Abstract][Full Text] [Related]
33. Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation.
Wulffraat NM; Rijkers GT; Elst E; Brooimans R; Kuis W
Rheumatology (Oxford); 2003 Feb; 42(2):375-9. PubMed ID: 12595640
[TBL] [Abstract][Full Text] [Related]
34. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.
Lehmberg K; Pink I; Eulenburg C; Beutel K; Maul-Pavicic A; Janka G
J Pediatr; 2013 Jun; 162(6):1245-51. PubMed ID: 23333131
[TBL] [Abstract][Full Text] [Related]
35. Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?
Ramanan AV; Grom AA
Rheumatology (Oxford); 2005 Nov; 44(11):1350-3. PubMed ID: 15956091
[TBL] [Abstract][Full Text] [Related]
36. [Multi-organ failure as first clinical sign of macrophage activation syndrome in childhood Still's disease].
López-Sánchez M; Rubio-López I; Obeso-González T; Teja-Barbero JL; Santidrián-Miguel JP; Peiro-Callizo E
An Pediatr (Barc); 2010 Oct; 73(4):194-8. PubMed ID: 20643591
[TBL] [Abstract][Full Text] [Related]
37. Biology and treatment of familial hemophagocytic lymphohistiocytosis: importance of perforin in lymphocyte-mediated cytotoxicity and triggering of apoptosis.
Henter JI
Med Pediatr Oncol; 2002 May; 38(5):305-9. PubMed ID: 11979453
[TBL] [Abstract][Full Text] [Related]
38. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.
De Benedetti F; Meazza C; Vivarelli M; Rossi F; Pistorio A; Lamb R; Lunt M; Thomson W; Ravelli A; Donn R; Martini A;
Arthritis Rheum; 2003 May; 48(5):1398-407. PubMed ID: 12746913
[TBL] [Abstract][Full Text] [Related]
39. Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis.
Avau A; Put K; Wouters CH; Matthys P
Cytokine Growth Factor Rev; 2015 Feb; 26(1):35-45. PubMed ID: 24948570
[TBL] [Abstract][Full Text] [Related]
40. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis.
Ramanan AV; Schneider R
J Rheumatol; 2003 Feb; 30(2):401-3. PubMed ID: 12563702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
